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OBJECTIVE: Traditionally, contiguous distribution of inflam-
mation (endoscopic and histological) with rectal involve-
ment is thought to be important in distinguishing ulcerative
colitis (UC) from Crohn’s disease of the colon. Little long-
term data are available that prove whether this rule holds
during the course of disease as it is modified by time and
treatment. The aim of this study was to investigate the
prevalence of endoscopic and histological patchiness and
rectal sparing in treated UC over time and to correlate these
findings with treatment at the time of endoscopy.
METHODS: Patients with well-established UC who under-
went sequential colonoscopy or flexible sigmoidoscopy with
biopsies were included in this study. Patients’ medical
records including endoscopy/biopsy reports and clinical sta-
tus/symptoms/treatment at the time of endoscopy were re-
viewed retrospectively.
RESULTS: A total of 32 patients (14 men, 18 women; median
age, 45 yr; median UC duration, 15 yr) underwent 175
sequential endoscopies with biopsies (161 colonoscopies,
14 sigmoidoscopies; median, five endoscopies per patient;
range, 3–10). Endoscopic and/or histological patchiness was
present in 20 of 175 (11%) sequential endoscopies with
biopsies over time from 12 of 32 (38%) patients. Endo-
scopic and/or histological rectal sparing was present in 27 of
175 (15%) of sequential endoscopies with biopsies over
time from 14 of 32 (44%) patients. Seven patients had both
patchiness and rectal sparing. Therefore, in 47 (27%) fol-
low-up endoscopies in 19 (59%) patients, there was either
patchy disease, rectal sparing, or both sometime during the
course of disease with treatment. There was no significant
difference in treatment, including steroid use and rectal
therapy, between those with patchiness and/or rectal sparing
and those without.
CONCLUSIONS: Contrary to traditional teaching, endoscopic
and histological patchiness of inflammation and rectal spar-
ing are common during the course of disease in treated UC
and seem to be unrelated to specific therapy. (Am J Gas-
troenterol 1999;94:3258–3262. © 1999 by Am. Coll. of
Gastroenterology)
INTRODUCTION
Ulcerative colitis and Crohn’s disease are differentiated by
a set of clinical, endoscopic, and histological characteristics
(1). There is no single endoscopic or histological finding
that is absolutely diagnostic of one disease or the other. One
of the characteristics that is believed to be important in
distinguishing ulcerative colitis from Crohn’s disease is the
pattern of endoscopic and histological distribution of in-
flammation. According to traditional teaching, ulcerative
colitis involves contiguous areas of the colon without skip
lesions, starting from the rectum (2–7). The presence of
patchy inflammation or rectal sparing in a patient with
previously diagnosed ulcerative colitis may lead to a change
of diagnosis to Crohn’s disease. Such a change in diagnosis
may have a significant impact on management strategies.
For instance, a patient with intractable ulcerative colitis who
is found to have patchy involvement or rectal sparing may
not be considered a candidate for curative colectomy with
ileoanal pouch procedure because these distributions sug-
gest the possibility of Crohn’s disease.
To date, little long-term data are available on whether the
traditional teaching holds during the course of disease with
treatment. There have been a few studies that refute the
dogma regarding the classic distribution of inflammation in
treated ulcerative colitis (8–13). In some of these studies,
however, patients usually had one endoscopy with biopsy
and were not followed further with subsequent endoscopy.
Also, these studies adopted less strict definitions of patchi-
ness and rectal sparing and included cases with relative
patchiness or rectal sparing based on endoscopic and histo-
logical differences in the severity of inflammation. One
recent study has suggested that the extent and the pattern of
distribution of inflammation in chronic ulcerative colitis
may vary significantly after 1 yr of treatment (14). Our
previous study was the first to investigate the prevalence of
histological patchiness or rectal sparing in patients with
treated ulcerative colitis over time based upon sequential
endoscopies with biopsies (13). In this study, we expand
upon that report by providing a detailed endoscopic and
clinical arm and correlating it with histological data to
describe patchiness and rectal sparing in patients with well-
established ulcerative colitis who underwent sequential en-
doscopies with biopsies over as long a period as 13 yr.
The results of this study were presented at the American College of Gastroenter-
ology 63rd Annual Scientific Meeting, Boston, Massachusetts, October 1998.
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MATERIALS AND METHODS
Patients with well-documented ulcerative colitis followed at
the University of Michigan Medical Center Gastroenterol-
ogy Clinic who underwent sequential colonoscopy or flex-
ible sigmoidoscopy with biopsies for dysplasia surveillance
or for disease flare were included in this study. Only patients
with at least three separate sets of biopsies over at least a
2-yr period were included. The patients were selected as
they were identified during regular biopsy diagnostic sign-
out in our pathology department. The diagnosis of ulcerative
colitis was established by widely accepted clinical, endo-
scopic, and histological criteria (6, 7, 15, 16).
The patients’ medical records were reviewed retrospec-
tively. Patient data reviewed included demographics, dura-
tion of disease, extent and severity of disease at the time of
diagnosis, endoscopy/biopsy findings, and patients’ clinical
status at the time of endoscopy/biopsy (flare, settling of
flare, or remission). Clinical parameters reviewed included
stool consistency and number of bowel movements per day,
presence or absence of hematochezia, and treatment and
response at the time of the procedure. Endoscopy/biopsy
findings were considered to reflect steroid use and rectal
therapy if these were used within 1 month of the procedure.
All biopsy slides were reviewed again by experienced
gastrointestinal (GI) pathologists. Histological details in-
cluding representative photographs have been recently pub-
lished (13). Each colorectal biopsy was classified as definite
or suspicious for chronic colitis, or normal. The biopsy was
classified as definite chronic colitis when there was an
obvious expansion of the lamina propria by plasma cells
and/or eosinophils, and/or accompanying mucosal distor-
tion. It was classified as suspicious for chronic colitis when
there was minimal distortion without lamina propria inflam-
mation, or if there were scattered metaplastic Paneth cells in
the left colon or rectum without mucosal distortion or lam-
ina propria inflammation.
Patchiness was defined as areas of normal mucosa (en-
doscopically and/or histologically) amid areas of apparent
inflammation. Rectal sparing was defined as a normal rec-
tum (endoscopically and/or histologically) when definite
proximal disease was present. Relative patchiness and rectal
sparing based on anatomic regional differences in the se-
verity of inflammation were not included in this study.
Endoscopy and biopsy reports were compared, in terms of
extent and severity of disease and the presence or absence of
patchiness and/or rectal sparing. The endoscopic severity of
disease was graded as mild, moderate, or severe by impres-
sions on endoscopy reports based on widely accepted en-
doscopic criteria (1). The histological severity of disease
was graded as mild, moderate, or severe based on the
intensity of chronic inflammation (plasma cells, eosino-
phils), degree of mucosal distortion, and amount of neutro-
phil activity. Endoscopic and histological correlation, in
terms of severity, was considered to be absent only when
endoscopic and histological impressions differed by at least
two grades (normalvsmoderate to severe or mildvssevere).
The data were analyzed using thex2 test. Statistical
significance was defined as ap value,0.05.
RESULTS
Thirty-two patients were included in this study. There were
14 men and 18 women with a median age of 45 yr (range,
18–83 yr). The median duration of disease was 15 yr,
ranging from 4 to 39 yr. The initial extent of disease at the
time of diagnosis included proctitis in two, proctosigmoid-
itis in five, so-called “distal colitis” in three, left-sided colitis
in three, colitis from rectum to transverse colon in two, and
pancolitis in seven patients; it was poorly described or not
clearly classified in 10 patients. A total of 175 sequential
endoscopies with biopsies (161 colonoscopies, 14 sigmoid-
oscopies; median of five endoscopies per patient; range,
three to 10) were performed in these patients over as long as
a 13-yr period.
Endoscopic and/or histological patchiness was present in
20 of 175 (11%) sequential endoscopies with biopsies over
time from 12 of 32 (38%) patients. In these 12 patients, six
endoscopic, 10 histological, and four combined endoscopic/
histological episodes of patchiness were present (Table 1).
Three patients had endoscopic patchiness only: two patients
had one episode each and one patient had two episodes on
two different occasions. Five patients had histological
patchiness only: four patients had one episode each and one
patient had four episodes on four different occasions. Three
patients had both endoscopic and histological patchiness at
the same time: two patients had one episode each and one
patient had two episodes on two different occasions. One
patient had both endoscopic and histological patchiness over
time, but only one type on each occasion: two endoscopic
and two histological episodes on four different occasions.
Endoscopic and/or histological rectal sparing was present
in 27 of 175 (15%) sequential endoscopies with biopsies
over time in 14 of 32 (44%) patients. In these 14 patients, 15
endoscopic, 10 histological, and two combined endoscopic/
histological episodes of rectal sparing were present (Table
2). Five patients had endoscopic rectal sparing only: four
patients had one episode each and one patient had three
episodes on three different occasions. Four patients had





Endoscopic only 3 4
Histological only 5 8
Endo/histo* 3 4
Endo and histo† 1 4
Total 12/32 (38%) 20/175 (11%)
* Combined endo/histo patchiness at the same time.
† Both endo and histo patchiness over time, but only one type on each occasion.
Endo5 endoscopic; histo5 histological.
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histological rectal sparing only: two patients had one epi-
sode each and two patients had two episodes on two differ-
ent occasions. One patient had both endoscopic and histo-
logical rectal sparing at the same time on one occasion.
Three patients had both endoscopic and histological rectal
sparing over time, but only one type on each occasion: one
patient had three endoscopic and one histological episodes
on four different occasions, one patient had two endoscopic
and one histological episodes on three different occasions,
and one patient had one endoscopic and one histological
episodes on two different occasions. One patient had endo-
scopic, histological, and endoscopic/histological rectal spar-
ing over time (only one type on each occasion): two endo-
scopic, one histological, and one combined endoscopic/
histological episodes on four different occasions.
Seven patients had both patchiness and rectal sparing.
Therefore, in 19 patients (59%), 47 episodes (27%) of
endoscopic and/or histological patchiness and/or rectal spar-
ing were present some time during the course of disease
with treatment.
The most common single treatment at the time of the
procedures was sulfasalazine in all groups of patients (Table
3). Seven episodes in the group with patchiness (35%),
seven episodes in the group with rectal sparing (26%), and
25 episodes in the group without patchiness or rectal sparing
(20%) were treated with sulfasalazine alone at the time of
the procedure. Three episodes (15%) in the group with
patchiness and eight episodes (30%) in the group with rectal
sparing, and 30 episodes (23%) in the group without patch-
iness or rectal sparing were treated with a steroid, usually in
combination with other medications. Five episodes (18%) in
the group with rectal sparing, two episodes in the group with
patchiness (10%), and 17 episodes (13%) in the group
without rectal sparing or patchiness were treated with rectal
therapy (either steroid or mesalamine enemas).
In 90 episodes (51%) there was lack of endoscopic and
histological correlation. The lack of correlation was based
on the extent of disease in 52 episodes, on severity in seven,
and on both the extent of disease and severity in 11 epi-
sodes; in 17 episodes endoscopy was normal but histolog-
ical evidence of at least moderate colitis was present; in
three episodes, histology was normal but endoscopic evi-
dence of colitis was present.
Endoscopic and/or histological disease reverted to normal
in 23 (13%) episodes in 12 patients (38%) some time during
the course of disease. These patients had endoscopic and/or
histological evidence of colitis on subsequent endosco-
py(ies).
None of the patients with patchiness and/or rectal sparing
developed any symptoms or complications suggestive of
Crohn’s disease during the study period, and their diagnosis
of ulcerative colitis remained unchanged.
DISCUSSION
To the best of our knowledge, this is the first study that
investigated the prevalence of both endoscopic and histo-
logical patchiness and rectal sparing in patients with treated
ulcerative colitis over time with sequential endoscopic bi-
opsies. Also, in this study patchiness and rectal sparing were
defined in absolute terms (present or absent), and cases with
relative patchiness and/or rectal sparing were not included.
Contrary to traditional teaching on the classic distribution
of inflammation in ulcerative colitis, our data show that
endoscopic and/or histological patchiness and rectal sparing
are not uncommon findings in patients with longstanding
treated ulcerative colitis over time. Nineteen of 32 patients
(59%) with well-documented ulcerative colitis in our study
had patchiness and/or rectal sparing (endoscopic and/or
histological) some time during the course of their disease.
Twelve patients (38%) had 20 episodes of patchiness, and
14 patients (44%) had 27 episodes of rectal sparing. The
episodes of patchiness and rectal sparing were found endo-
scopically and histologically in an approximately equal dis-
tribution.
Our results are supported by the findings of previous
studies that challenged the dogma regarding the classic
distribution of inflammation in ulcerative colitis (8–12, 17).
A prospective study by Bernsteinet al. showed that of 39
patients with well-established ulcerative colitis, 17 patients
(44%) had endoscopic and 13 patients (33%) had histolog-
ical patchiness (including five with endoscopic and six with
histological rectal sparing), in absolute or relative terms (8).
Absolute patchiness or rectal sparing was present in five
patients (13%): three with endoscopic patchiness and two
with histological rectal sparing. In this study, the patients
had only one endoscopy with biopsies and were not fol-
lowed further with subsequent endoscopy. We adopted a
strict definition of patchiness and rectal sparing and ex-





Endoscopic only 5 7
Histological only 4 6
Endo/histo* 1 1
Endo and histo† 4 13
Total 14/32 (44%) 27/175 (15%)
* Combined endo/histo rectal sparing at the same time.
† Both endo and histo rectal sparing over time but only one type on each occasion.
Endo5 endoscopic; histo5 histological.












Sulfasalazine 7 (35%) 7 (26%) 25 (20%)
Steroid* 3 (15%) 8 (30%) 30 (23%)
Rectal therapy 2 (10%) 5 (18%) 17 (13%)
* Most patients were treated with a steroid in combination with other medications,
such as mesalamine and sulfasalazine.
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cluded cases with relative disease. The prevalence of abso-
lute patchiness/rectal sparing in our study of 59% of the
patients is clearly higher than the 13% prevalence identified
in the Bernstein series. This difference is probably due to the
long-term endoscopic follow-up in our patients and suggests
that with repeated biopsies over the course of years, findings
of patchiness/rectal sparing are not only possible but per-
haps are to be expected.
D’Haenset al., in a prospective study employing com-
plete ileocolonoscopy on 20 patients with established left-
sided ulcerative colitis, found a high prevalence of isolated
proximal patchy inflammation (9). Fifteen patients (75%)
had a patch of inflammation (both endoscopic and histolog-
ical) in the cecum. In all cases this patch of inflammation
was separated from the obviously inflamed distal segment
by normal mucosa or mucosa with only borderline changes
(endoscopically and/or histologically); the terminal ileum
appeared normal in all cases. Upon follow-up of these
patients for at least 8 yr, none developed ileitis or anal
complications suggestive of Crohn’s disease, and their di-
agnosis remained unchanged. Interestingly, all 15 patients
had obvious patchy inflammation in the periappendiceal
area of the cecum with a normal or relatively normal as-
cending and transverse colon. The significance of this pat-
tern of disease involvement in these patients indicates that
skip lesions do occur in ulcerative colitis, a challenge to
conventional dogma about the distribution of changes in
ulcerative colitis as opposed to Crohn’s disease. However,
this is a different finding from the changing nature of treated
disease with respect to the patchiness that we are describing.
The prevalence of rectal sparing in treated ulcerative
colitis has been investigated in a few studies (10–12, 18). In
a series of 12 patients who had been categorized as having
ulcerative colitis with predominantly right-sided disease or
relative rectal sparing, six (50%) had a normal sigmoido-
scopic appearance with evidence of proximal disease on
double-contrast barium enema (18). In these patients, how-
ever, rectal biopsies showed changes compatible with ul-
cerative colitis (three with only mild changes). Oshitaniet
al. reported nine of 30 patients (30%) with ulcerative colitis
who had absolute or relative endoscopic rectal sparing;
however, no biopsies were taken in this study (11). In 14
patients enrolled in a topical 5-aminosalicylic acid treatment
trial, nine patients (64%) were later found to have normal
rectal biopsies, although, interestingly, two had been treated
with placebo (12). More recently, Levineet al.found that 11
of 24 patients (46%) with well-documented ulcerative co-
litis had normal or only borderline abnormal rectal biopsies
(two with normal biopsies); they did not describe endo-
scopic findings (10). These studies were limited to rectal
sparing, and except for one study, did not attempt to corre-
late endoscopic findings with histological findings (18).
Finally, in untreated ulcerative colitis, patchy inflamma-
tion and rectal sparing have been described in children.
Markowitz et al. reported that five of 12 children with
proven ulcerative colitis by examination of a subtotal co-
lectomy specimen had either mild patchy inflammation or
rectal sparing on biopsies at their disease onset (19). It is not
clear whether these data can be extrapolated to adult pa-
tients, but it suggests the possibility that patchy inflamma-
tion and rectal sparing can occur even in patients with
untreated ulcerative colitis.
In our study, there was no significant difference in treat-
ment between those with patchiness and/or rectal sparing
and those without. The most common single treatment in all
groups of patients was sulfasalazine. Thirty-five percent of
episodes with patchiness, 26% of episodes with rectal spar-
ing, and 20% of episodes without patchiness or rectal spar-
ing were treated with sulfasalazine alone at the time of
procedure; the difference was not statistically significant.
There was also no difference between patients with patch-
iness and/or rectal sparing and those without based upon the
use of oral steroids. Even topical therapy appeared to have
little influence on rectal histology in our ulcerative colitis
patients. We found that 18% of episodes with rectal sparing
and 13% of episodes without rectal sparing were treated
with topical rectal therapy, either mesalamine or steroid
enemas (p 5 0.43). Previously mentioned studies also
showed no difference in the use of enemas between patients
with rectal sparing and those without (8, 11). In the pro-
spective mesalamine enema treatment trial discussed earlier,
the patients treated with mesalamine enemas had a higher
average number of normal rectal biopsies per patient than
those treated with placebo enemas (3vs1.3) (12). However,
these were patients with active left-sided colitis on a treat-
ment protocol and our patients were biopsied during varying
degrees of disease activity and treatment. Under chronic
conditions, the use of medication at the time endoscopy with
biopsy is performed appears to have little influence on the
presence of patchiness and rectal sparing.
A recent study by Moumet al. suggested that the dis-
crepancy between endoscopic and histological involvement
in ulcerative colitis patients increases with time (14). In this
study, histopathological examination showed more exten-
sive disease than endoscopic findings in 4% at diagnosis and
in 28% at follow-up in 1 yr, whereas endoscopic findings
showed more extensive disease than histopathological ex-
amination in 18% at diagnosis and 12% at follow-up. Our
results show lack of correlation between endoscopic and
histological findings in 51% of episodes. Evidence of his-
tological disease was present in 17 episodes with endoscop-
ically normal mucosa, and histologically normal mucosa
appeared abnormal endoscopically in three episodes. Thus,
our results suggest that lack of endoscopic and histological
correlation is not uncommon in patients with treated long-
term ulcerative colitis. To assess the maximal extent and
severity of disease in patients with ulcerative colitis, biop-
sies should be taken from normal-appearing as well as
abnormal-appearing mucosae, and both endoscopic and his-
tological findings should be considered.
In summary, our results defy the traditional rule requiring
the presence of contiguous distribution of inflammation with
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rectal involvement in ulcerative colitis. Patchy distribution
of inflammation and rectal sparing are common in patients
with treated ulcerative colitis, and do not seem to be related
to any specific treatment, including steroid use and rectal
therapy. Our results support and extend the findings of a few
previous studies by so-called “revisionists” (8–12). The
finding of patchy inflammation and/or rectal sparing alone
in patients with previously diagnosed ulcerative colitis
should not necessarily lead to a change of diagnosis to
Crohn’s disease; comprehensive evaluation including care-
ful review of previous biopsies should be done before rais-
ing the suspicion of Crohn’s disease. In patients with ulcer-
ative colitis, the extent and the pattern of distribution of
inflammation may vary significantly over time with treat-
ment, including reversion to normal mucosa, and lack of
endoscopic and histological correlation appears to be rela-
tively common.
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